1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Rate and risk factors for thromboembolism and major bleeding in adults with congenital heart disease taking vitamin K antagonist therapy
(
- Contribution to journal › Article
- 2021
-
Mark
Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease : TTR and INR variability
(
- Contribution to journal › Letter
- 2004
-
Mark
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
(
- Contribution to journal › Article
- 2002
-
Mark
Sekundärproylax efter hjärninfarkt utan kardiell embolikälla. Antikoagulantia inte bättre än ASA enligt ny stor studie (WARSS)
(
- Contribution to journal › Article
- 1999
-
Mark
Samordnad svensk övergång rekommenderas under 1999. Protrombinkomplexmätning bör anges som en kvot, inte i procent
(
- Contribution to journal › Article